首页 › 基金 › SHEETS SMITH WEALTH MANAGEMENT › IBRX
SHEETS SMITH WEALTH MANAGEMENT 对 IBRX 的持仓历史
IMMUNITYBIO INC · 医疗保健
SHEETS SMITH WEALTH MANAGEMENT 在 Q3 2026 的 13F 申报中披露持有 IBRX(IMMUNITYBIO INC)512,572 股,市值约 US$4.8M,约占其申报组合的 0.51%,在其申报持仓中市值排名第 48 位。 SHEETS SMITH WEALTH MANAGEMENT 最近 13 个申报季度中有 13 个季度披露了 IBRX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-16 · 来源: SEC EDGAR Form 13F-HR
SHEETS SMITH WEALTH MANAGEMENT 对 IBRX 的持仓演变
SHEETS SMITH WEALTH MANAGEMENT 于 Q3 2023 首次披露 IBRX 持仓:273,879 股(约 US$463K)。 该持仓在 Q1 2024 达到峰值 945,720 股,市值约 US$5.1M。 在 13 次申报中,SHEETS SMITH WEALTH MANAGEMENT 1 次增持、5 次减持、6 次保持不变。 最近一期申报(Q3 2026)显示持股 512,572 股、市值约 US$4.8M。 持仓曾出现大幅变动:Q4 2023 减持约 28% (随后一个季度股价上涨 7%)、Q1 2024 增持约 381% (随后一个季度股价上涨 18%)、Q2 2024 减持约 30% (随后一个季度股价下跌 41%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 273.88K | $462.86K | 新进 |
| Q4 2023 | 196.68K | $987.33K | 减持 |
| Q1 2024 | 945.72K | $5.08M | 增持 |
| Q2 2024 | 666.00K | $4.21M | 减持 |
| Q3 2024 | 666.00K | $2.48M | 持有 |
| Q4 2024 | 633.98K | $1.62M | 减持 |
| Q1 2025 | 633.48K | $1.91M | 持有 |
| Q2 2025 | 633.48K | $1.67M | 持有 |
| Q3 2025 | 633.08K | $1.56M | 持有 |
| Q4 2025 | 631.98K | $1.25M | 持有 |
| Q1 2026 | 552.02K | $4.23M | 减持 |
| Q2 2026 | 512.57K | $4.49M | 减持 |
| Q3 2026 | 512.57K | $4.84M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 IBRX 与 13F 数据
IBRX(IMMUNITYBIO INC)属于医疗保健行业。我们追踪的基金中还有 68 只申报持有 IBRX,申报仓位最大的包括:GREAT POINT PARTNERS LLC (US$26.3M), VESTOR CAPITAL, LLC (US$12.1M), Sound Capital Solutions LLC (US$9.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 IBRX 的基金
- GREAT POINT PARTNERS LLC 3.00M 股 · $26.27M · Q2 2026
- VESTOR CAPITAL, LLC 44.84K 股 · $12.05M · Q2 2026
- Sound Capital Solutions LLC 1.12M 股 · $9.81M · Q2 2026
- Clearwater Capital Advisors, LLC 717.52K 股 · $6.28M · Q2 2026
- ALLEN HOLDING INC /NY 687.57K 股 · $6.02M · Q2 2026
- Kercheville Advisors, LLC 613.38K 股 · $5.79M · Q3 2026
- Legacy Capital Group California, Inc. 446.00K 股 · $3.90M · Q2 2026
- MOR Wealth Management, LLC 302.45K 股 · $2.65M · Q2 2026
- NIA IMPACT ADVISORS, LLC 270.17K 股 · $2.37M · Q2 2026
更多关于 SHEETS SMITH WEALTH MANAGEMENT
常见问题
How long has SHEETS SMITH WEALTH MANAGEMENT held IBRX?
SHEETS SMITH WEALTH MANAGEMENT has disclosed IBRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is SHEETS SMITH WEALTH MANAGEMENT's current position in IBRX?
As of Q3 2026, SHEETS SMITH WEALTH MANAGEMENT holds 512.57K shares of IBRX (IMMUNITYBIO INC), valued at $4.84M, representing 0.51% of its reported portfolio and ranking #48.
Has SHEETS SMITH WEALTH MANAGEMENT been buying or selling IBRX?
In the latest 13F filing (Q3 2026), SHEETS SMITH WEALTH MANAGEMENT held unchanged its position in IBRX. The position peaked in Q1 2024 at 945.72K shares.
Which other funds hold IBRX?
Other major institutional holders of IBRX include GREAT POINT PARTNERS LLC, VESTOR CAPITAL, LLC, Sound Capital Solutions LLC, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.